bioMérieux Share Price
Stocks
BIM
FR0013280286
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 06:30:18 | |||
| 72.35 EUR | -0.69% |
|
71.38 | -1.35% |
| 06-04 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 06-01 | BioMérieux in the red following UBS downgrade |  |
| Capitalization | 8.53B 9.86B 7.85B 7.37B 13.73B 942B 13.95B 92.7B 36.16B 455B 36.98B 36.18B 1,578B | P/E ratio 2026 * |
17.1x | P/E ratio 2027 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise value | 8.08B 9.33B 7.43B 6.98B 13B 892B 13.21B 87.75B 34.23B 430B 35B 34.25B 1,494B | EV / Sales 2026 * |
1.96x | EV / Sales 2027 * | 1.77x |
| Free-Float |
33.22% | Yield 2026 * |
1.53% | Yield 2027 * | 1.6% |
Last Transcript: bioMérieux
Trading bioMérieux
| 1 day | -0.69% | ||
| 1 week | +1.19% | ||
| Current month | -2.69% | ||
| 1 month | +1.76% | ||
| 3 months | -24.16% | ||
| 6 months | -30.63% | ||
| Current year | -34.41% |
| 1 week | 70.15 |  | 74 |
| 1 month | 69.95 | | 74.85 |
| Current year | 68.05 | | 116.1 |
| 1 year | 68.05 | | 128.3 |
| 3 years | 68.05 | | 128.3 |
| 5 years | 68.05 | | 133.2 |
| 10 years | 36.33 | | 144.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 54 | 30/06/2023 |
| Director of Finance/CFO | 49 | 28/02/2018 | |
| Chief Tech/Sci/R&D Officer | - | 31/07/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 76 | 31/12/2013 | |
| Chairman | 52 | 14/12/2017 | |
| Director/Board Member | 65 | 31/12/2004 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-05 | Buy | Chairman | 779,245 | 0.6584% | ||
| 05-05 | Buy | Chairman | 779,245 | 0.6584% | ||
| 05-03 | Buy | Chairman | 404,367 | 0.3416% |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.69% | +1.19% | -40.70% | -21.43% | 9.85B | |
| -0.57% | -3.29% | +159.86% | +283.22% | 16.56B | |
| -0.96% | +2.97% | +22.64% | +12.65% | 6.51B | |
| +0.56% | -3.95% | -28.95% | -20.48% | 5.19B | |
| -2.12% | -1.88% | - | - | 4.56B | |
| 0.00% | +5.02% | -23.69% | -27.48% | 4.3B | |
| -3.83% | -12.62% | +80.53% | +70.86% | 4.2B | |
| -5.99% | -1.39% | +209.77% | -46.28% | 3.7B | |
| -2.89% | -6.01% | -22.27% | -44.31% | 2.55B | |
| +1.40% | -0.76% | -38.06% | -55.23% | 1.4B | |
| Average | -1.51% | -1.68% | +35.46% | +16.84% | 5.88B | |
| Weighted average by Cap. | -1.24% | -1.49% | +57.99% | +78.74% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.12B 4.75B 3.79B 3.56B 6.63B 454B 6.73B 44.72B 17.44B 219B 17.84B 17.45B 761B | 4.38B 5.06B 4.03B 3.78B 7.05B 484B 7.16B 47.59B 18.56B 233B 18.98B 18.57B 810B |
| Net income | 506M 584M 465M 437M 814M 55.85B 827M 5.5B 2.14B 26.95B 2.19B 2.14B 93.58B | 561M 648M 516M 485M 903M 61.94B 917M 6.09B 2.38B 29.89B 2.43B 2.38B 104B |
| Net Debt | -455M -526M -419M -393M -733M -50.28B -745M -4.95B -1.93B -24.26B -1.97B -1.93B -84.25B | -793M -916M -729M -685M -1.28B -87.53B -1.3B -8.61B -3.36B -42.24B -3.44B -3.36B -147B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/06/26 | 72.35 € | -0.69% | 133,695 |
| 05/06/26 | 72.85 € | -0.75% | 145,799 |
| 04/06/26 | 73.40 € | +3.67% | 157,293 |
| 03/06/26 | 70.80 € | +1.00% | 141,467 |
| 02/06/26 | 70.10 € | -1.96% | 155,896 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition